Group One Trading’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Group One Trading’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,900	Closed	-$9K	–	9093
2021 Q3	$9K	Buy	+1,900	New	+$8.36K	﹤0.01%	7573

Group One Trading's LOGC Position: Q4 2022 in Review

Group One Trading sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q4 2022, closing a stake of 1,200 shares.

Group One Trading first reported a position in LOGC in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold LOGC as of Q4 2022.

Group One Trading reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Group One Trading sold 1,200 LogicBio Therapeutics, Inc. Common Stock shares in Q4 2022.
Group One Trading first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Group One Trading's LogicBio Therapeutics, Inc. Common Stock position peaked at $3K in Q4 2021.
0 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.